Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2026)

Beta Bionics' Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $623000.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 99.7% year-over-year to $623000.0; the TTM figure through Mar 2026 stood at $4.4 million (down 98.36% YoY), while the FY2025 annual figure was $214.9 million, up 286.36% from the prior year.
• Cash from Financing Activities came in at $623000.0 for Q1 2026 at Beta Bionics, down from $1.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $211.1 million in Q1 2025 to a low of -$1.2 million in Q3 2024.
• A 3-year average of $30.1 million and a median of $623000.0 in 2026 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities jumped 3518550.0% in 2025 and tumbled 99.7% in 2026, its largest moves.
• Beta Bionics' Cash from Financing Activities stood at $56.9 million in 2024, then tumbled by 98.14% to $1.1 million in 2025, then plunged by 41.23% to $623000.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $623000.0, $1.1 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison